Clearmind Medicine Inc.
CMND · NASDAQ
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Market Cap | $213,688 | $5,086 | $6,194 | $5,929 |
| - Cash | $3,495 | $4,473 | $5,781 | $6,574 |
| + Debt | $28 | $36 | $46 | $53 |
| Enterprise Value | $210,222 | $649 | $459 | -$592 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$13 | -$12 | -$12 | -$12 |
| % Margin | – | – | – | – |
| EBITDA | -$1,284 | -$1,295 | -$1,012 | -$1,180 |
| % Margin | – | – | – | – |
| Net Income | -$1,314 | -$784 | -$1,072 | -$885 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.25 | -6.4 | -9.6 | -8.4 |
| % Growth | 96.1% | 33.3% | -14.3% | – |
| Operating Cash Flow | -$1,503 | -$1,098 | -$1,265 | -$1,085 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$1,503 | -$1,098 | -$1,265 | -$1,085 |